Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Primärer Hypoaldosteronismus, Pseudo-Hypoaldosteronismus und distal-tubuläre Acidose

Primary hypoaldosteronism, pseudohypoaldosteronism, and renal tubular acidosis

  • 29 Accesses

  • 1 Citations


Aldosterone deficiency is caused by (1) various defects of aldosterone biosynthesis in the adrenal gland or (2) hyporeninism. The most important symptoms are hyponatremia and hyperkalemia. These electrolyte disturbances are also found in pseudohypoaldosteronism. Pseudohypoaldosteronism type I is characterized by insensitivity of the distal nephron for aldosterone. Hyperabsorption of chloride in the distal nephron leads to pseudohypoaldosteronism type II, which is linked with hypertension, whereas blood pressure in the other mentioned disorders is decreased. Renal tubular acidosis, mainly type 4, with impaired production of ammonia due to hyperkalemia, is frequently observed in hypoaldosteronism and both types of pseudohypoaldosteronism as well. The therapeutic regimen is different: (1) low doses of fludrocortisone in hypoaldosteronism, (2) potassium restriction, sodium bicarbonate and loop diuretics in type I of pseudohypoaldosteronism, and (3) sodium restriction and chloruretic diuretics (thiazide) in type II of pseudohypoaldosteronism. In some cases hyperkalemia requires the use of potassium-binding resins.

This is a preview of subscription content, log in to check access.


  1. 1.

    Arnold JE, Healy JK (1969) Hyperkalemia, hypertension and systemic acidosis without renal failure associated with a tubular defect in potassium excretion. Am J Med 47:461

  2. 2.

    Batlle D, Grupp M, Gaviria M, Kurtzmann NA (1982) Distal renal tubular acidosis with intact capacity to lower urinary pH. Am J Med 72:751

  3. 3.

    Bierich JR, Schmidt U (1976) Tubular Na, K-ATPase deficiency, the cause of the congenital renal salt-losing syndrome. Eur J Pediatr 121:81

  4. 4.

    Cheek DB, Perry JW (1958) A salt-wasting syndrome in infancy. Arch Dis Child 33:252

  5. 5.

    Cogan MC, Arieff AJ (1978) Sodium wasting, acidose and hyperkalemia, induced by methicillin interstitial nephritis. Am J Med 64:500

  6. 6.

    Degenhardt HJ, Frankena L, Visser HKA, Cost WS, van Seters AP (1966) Further investigation of a new hereditary defect in the biosynthesis of aldosterone: evidence for a defect in 18-hydroxylation of corticosterone. Acta Physiol Pharmacol 14:88

  7. 6a.

    Donnell GN, Litman N, Roldan M (1959) Pseudohypoadrenalocorticism. Am J Dis Child 97:813

  8. 7.

    Farfel Z, Iaina A, Rosenthal T, Waks U, Shibolet S, Gafni J (1978) Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels. Possible hereditary cell membrane defect. Arch Int Med 138:1828

  9. 8.

    Gordon RD, Geddes RA, Pausey CGK, O'Halloran MW (1970) Hypertension and severe hyperkalemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Aust Ann Med 4:287

  10. 9.

    Kotchen TA, Galla JH, Luke RG (1978) Contribution of chloride to the inhibition of plasma renin by sodium chloride in the rat. Kidney Int 13:201

  11. 10.

    Oberfield SE, Levine LS, Carey RM, Bejar R, New MI (1979) Pseudohypoaldosteronism: multiple target organ unresponsiveness to mineralicorticoid hormones. J Clin Endocrinol Metab 48:228

  12. 10a.

    Postel-Vinay MC, Alberti GM, Ricour C, Limal JM, Rappaport M, Royer P (1974) Pseudohypoaldosteronism: Persistence of hyperaldosteronism and evidence for renal tubular and intestinal responsiveness to endogenous aldosterone. J Clin Endocrinol Metab 39:1038

  13. 11.

    Rösler A, Rabinowitz D, Theodor R, Ramirez L, Ulick S (1977) The nature of the defect in a salt wasting disorder in Jews of Iran. J Clin Endocrinol Metab 44:279

  14. 12.

    Rösler A, Theodor R, Boichis H, Gerty R, Ulick S, Cohen B (1977) Metabolic responses to the administration of angiotensin II, K and ACTH in two salt-wasting syndromes. J Clin Endocrinol Metab 44:292

  15. 13.

    Schambelan M, Sebastian A, Rector FC Jr (1981) Mineralocorticoid-resistant renal hyperkalemia without salt wasting (typ II pseudohypoaldosteronism). Kidney Int 19:716

  16. 14.

    Schambelan M, Sebastian A, Hulter HN (1978) Mineralocorticoid excess and deficiency syndromes. In: Brenner BM, Stein JH (eds) Contemporary issues in nephrology, vol II. Churchill-Livingstone, New York, p 232

  17. 15.

    Schambelan M, Sebastian A, Rector FC Jr (1978) Mineralocorticoid resistant renal potassium (K+) secretory defect: Proposed distal tubule chloride shunt. Clin Res 26:545 [Abstr]

  18. 16.

    Schambelan M, Stockigt R, Biglieri EG (1972) Isolated hypoaldosteronism in adults. New Engl J Med 287:573

  19. 17.

    Sebastian A, Hulter HN, Kurtz I, Maher T, Schambelan M (1982) Disorders of distal nephron function. Am J Med 72:289

  20. 18.

    Sebastian A, Schambelan M, Lindenfeld S, Morris RC Jr (1977) Ameloriation of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism. New Engl J Med 297:567

  21. 19.

    Spitzer A, Edelmann CM Jr, Goldberg LD, Henneman PH (1973) Short stature, hyperkalemia and acidosis: a defect in renal transport of potassium. Kidney Int 3:251

  22. 20.

    Stanbury SW, Mahler RF (1959) Salt-wasting renal disease. Metabolic observations on a patient with “salt-losing nephritis”. Q J Med 28:425

  23. 21.

    Szylman P, Better OS, Chaimowitz C, Rösler A (1976) Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism. New Engl J Med 294:361

  24. 22.

    Ulick S, Gautier E, Vetter K, Markello JR, Yaffe S, Lowe CV (1964) An aldosterone biosynthesic defect in a salt-losing disorder. J Clin Endocrinol Metab 24:669

  25. 23.

    Ulick S (1976) Diagnosis of disorders of the aldosterone biosynthetic pathway. J Clin Endocrinol Metab 43:92

  26. 24.

    Ulick S, Nicolis GL, Vetter K (1964) Relationship of 18-hydroxycorticosterone to aldosterone. In: Baulieu EG, Robel P (eds) Aldosterone. Blackwell, Oxford, pp 3–24

  27. 25.

    Vagnucci AH (1970) Selective aldosterone deficiency in chronic pyelonephritis. Nephron 7:524

  28. 26.

    Veldhuis JD, Melby JC (1981) Isolated aldosterone deficiency in man. Endocr Rev 2:495

  29. 27.

    Veldhuis JD, Kulin HE, Santen RJ, Wilson TE, Melby JC (1980) Inborn error in the terminal step of aldosterone biosynthesis: Corticosterone methyloxidase defect type II. New Engl J Med 303:117

  30. 28.

    Walker GW, Jost LJ, Johnson JR, Kowarski A (1965) Metabolic observation on salt wasting in a patient with renal disease. Am J Med 39:505

  31. 29.

    Weinstein SF, Allan DME, Mendoza SA (1974) Hyperkalemia, acidosis and short stature, associated with a defect in renal potassium excretion. J Pediatr 85:335

  32. 30.

    Williams GH, Dluhy RG, Thorn GW (1978) Disease of the adrenal cortex. In: Isselbacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD (eds) Harrison's principles of internal medicine, 9th edn. McGraw-Hill, New York, p 1733

  33. 31.

    Klaus D, Lederle RM, Vecsei P (1984) Primärer Hypoaldosteronismus und sekundärer Pseudo-Hypoaldosteronismus. Klin Wochenschr 62:753–758

Download references

Author information

Additional information

Herrn Prof. Dr. Dr. H.E. Bock in Verehrung zum 80. Geburtstag gewidmet

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Klaus, D. Primärer Hypoaldosteronismus, Pseudo-Hypoaldosteronismus und distal-tubuläre Acidose. Klin Wochenschr 62, 747–752 (1984). https://doi.org/10.1007/BF01721771

Download citation

Key words

  • Hypoaldosteronism
  • Pseudohypoaldosteronism
  • distal tubular Acidosis-Aldosteron-Biosynthesis Defects